Long-term outcomes after revascularization and medical therapy in premature coronary artery disease for
Farbod Ebadi Fard Azar1, Ali Aboutorabi2, Mohammad Afrouzi2
1Health Promotion Research Center, Iran University of Medical Sciences, Tehran, Iran.
Insights
This study compares long-term outcomes for premature coronary artery disease patients treated with coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), or medical therapy (MT). Findings inform cost-effectiveness analyses for these vital treatments.
Area of Science:
- Cardiology
- Health Economics
- Systematic Reviews
Background:
- Premature coronary artery disease (CAD) necessitates understanding long-term outcomes for effective cost-effectiveness analysis.
- Revascularization options include coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI), alongside medical therapy (MT).
Purpose of the Study:
- To systematically review and analyze the long-term outcomes of CABG, PCI, and MT in patients with premature CAD.
- To provide essential data for calculating event probabilities crucial for cost-effectiveness and cost-utility studies.
Main Methods:
- Systematic review of studies from major databases (PubMed, Web of Science, Scopus, Embase).
- Inclusion criteria: patients aged 18-60 years.
- Random-effects meta-analysis to assess long-term outcomes, reporting risk ratios and adverse event probabilities.
Main Results:
- The study will ascertain probabilities of adverse events over specific periods for each treatment modality.
- Outcomes will be compared based on specific patient characteristics.
Conclusions:
- This systematic review offers critical insights into the long-term outcomes of CABG, PCI, and MT for premature CAD.
- The findings are valuable for both clinical decision-making and economic evaluations, including cost-effectiveness and cost-utility analyses.
Background:
The long-term outcomes are important concepts for cost-effectiveness analysis in patients with premature coronary artery disease after revascularization (coronary artery bypass grafting [CABG] and percutaneous coronary intervention [PCI]) and medical therapy (MT). The finding of this study will be used to calculate the events probabilities for cost-effectiveness study.
Methods And Analysis:
This systematic review will use studies in which patients age must be 18-60 years in eligible studies that obtained from PubMed, Web of Science, Scopus, and Embase. We will assess the long-term outcomes after CABG, PCI, and MT by random-effects meta-analysis and effects will be shown by risk ratio. We will ascertain the probabilities of adverse events during certain periods and then outcomes will compare separately based on specific characteristics.
Conclusion:
This study will provide information related to outcomes of CABG, PCI, and MT in patients with premature coronary artery disease. Doing this systematic review is valuable from clinically and economically aspects such as cost-effectiveness and cost-utility analysis.
More Related Videos
05:07Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Mitral Stenosis III: Medical Management
